TrialThe Journal of infectious diseases2025

EDP-938 Has a High Barrier to Resistance in Healthy Adults Experimentally Infected with Respiratory Syncytial Virus.

Rachel Emily Levene et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.